Clariant Expands Specialty Chemicals Production with CHF 80 Million Investment in China
Clariant has completed an CHF 80 million expansion of its Daya Bay facility in China, enhancing manufacturing capabilities for pharmaceutical excipients and specialty chemicals in personal and home care markets. The upgraded site features increased capacity for polyethylene glycols and specialty surfactants, supporting local industries and consumer demand with sustainable and innovative products.
Clariant's strategic CHF 80 million investment in its Daya Bay, China facility significantly boosts production capacity across pharmaceutical excipients and specialty chemicals used in personal and home care applications. The expansion includes a new spray tower serving southern China, reinforcing Clariant’s role as a key API and excipient supplier, with products such as VitiPure™, Polyglykol™, Lanogen™, and Motusflex™. The multi-purpose plant was enhanced with an additional reactor to produce mild surfactants and soil release polymers under the Texcare™ brand, catering to the rising demand for gentle personal care and advanced home care solutions. Clariant's enhanced portfolio also addresses sustainable chemistry challenges, offering low-VOC coatings, synthetic lubricants, crop protection additives, and soil health enhancers. The broader chemical product range now includes increased Ethylene Oxide Derivatives output. These developments reflect Clariant’s long-term commitment to the Chinese market and its aim to advance innovation and sustainability while meeting evolving consumer and industrial needs in Asia.
